Evidence map›Paper›PMID 33043043›Full record

ReviewERJ open research2020

ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly.

Clairelyne Dupin, Vânia Fernandes, Fernanda Hernandez-Gonzalez, Sebastiano Emanuele Torrisi, Tiago M Alfaro, Michael Kreuter, Marlies S Wijsenbeek, Elisabetta A Renzoni, Elena Bargagli, Hilario Nunes and 5 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Clairelyne DupinNational Reference Centre for Histiocytoses, Pneumology Dept, Saint-Louis Hospital, Paris, France.ORCID https://orcid.org/0000-0001-7957-8195
Vânia FernandesUnit of Respiratory Medicine, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Fernanda Hernandez-GonzalezDept of Pulmonology, ICR, Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
Sebastiano Emanuele TorrisiRegional Centre for Interstitial and Rare Lung Diseases, Dept of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Tiago M AlfaroUnit of Respiratory Medicine, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.ORCID https://orcid.org/0000-0001-6490-0620
Michael KreuterCenter for Interstitial and Rare Lung Diseases, Pneumology Thoraxklinik, University of Heidelberg and German Center for Lung Research, Heidelberg, Germany.
Marlies S WijsenbeekDept of Respiratory Medicine, Erasmus Medical Center, University Hospital Rotterdam, Rotterdam, The Netherlands.
Elisabetta A RenzoniInterstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
Elena BargagliSection of Respiratory Diseases and Lung Transplantation, Dept of Clinical Medicine and Neurosciences, Siena University Hospital, Siena, Italy.
Hilario NunesAssistance Publique - Hôpitaux de Paris, Avicenne Hospital, Pneumology Dept, Centre de Référence des Maladies Pulmonaires Rares (site constitutif), Bobigny, France.
Paolo SpagnoloSection of Respiratory Diseases, Dept of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Francesco BonellaDivision Interstitial and Rare Lung Disease, Dept of Pulmonary Medicine, University Hospital - Ruhrlandklinik, Essen, Germany.ORCID https://orcid.org/0000-0001-7579-9767
Maria Molina-MolinaILD Unit, Dept of Pneumology, Bellvitge University Hospital, Barcelona, Spain.
Katerina AntoniouDept of Thoracic Medicine, Heraklion University Hospital, Medical School, University of Crete, Heraklion, Greece.
Venerino PolettiDept of Diseases of the Thorax, Ospedale GB Morgagni, Forli, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article discusses a selection of the scientific presentations in the field of interstitial lung diseases (ILDs) that took place at the 2019 European Respiratory Society International Congress in Madrid, Spain. There were sessions from all four groups within Assembly 12: group 12.01 "Idiopathic interstitial pneumonias", group 12.02 "ILDs/diffuse parenchymal lung diseases (DPLDs) of known origin", group 12.03 "Sarcoidosis and other granulomatous ILDs/DPLDs" and group 12.04 "Rare ILDs/DPLDs". The presented studies brought cutting-edge developments on several aspects of these conditions, including pathogenesis, diagnosis and treatment. As many of the ILDs are individually rare, the sharing of experiences and new data that occur during the Congress are very important for physicians interested in ILDs and ILD patients alike.

Identifiers

PMID33043043
PMCPMC7533302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.